Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
American Well Corporation stock logo
AMWL
American Well
$6.85
+0.5%
$7.13
$5.00
$12.95
$106.85M1.1984,642 shs23,119 shs
Augmedix, Inc. stock logo
AUGX
Augmedix
$2.35
$2.34
$0.73
$6.25
$115.08M-0.22635,746 shsN/A
Forian Inc. stock logo
FORA
Forian
$2.15
+1.4%
$2.04
$1.85
$4.03
$67.08M1.0216,384 shs7,404 shs
Kamada Ltd. stock logo
KMDA
Kamada
$7.20
-0.3%
$6.78
$4.83
$9.16
$414.07M0.9494,376 shs55,533 shs
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
American Well Corporation stock logo
AMWL
American Well
0.00%+0.74%-7.55%-16.52%-7.50%
Augmedix, Inc. stock logo
AUGX
Augmedix
0.00%0.00%0.00%0.00%+192.47%
Forian Inc. stock logo
FORA
Forian
0.00%+10.26%+3.86%-0.92%-18.87%
Kamada Ltd. stock logo
KMDA
Kamada
0.00%+4.65%+8.60%+1.41%+50.63%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
American Well Corporation stock logo
AMWL
American Well
3.7642 of 5 stars
4.13.00.00.03.12.51.3
Augmedix, Inc. stock logo
AUGX
Augmedix
N/AN/AN/AN/AN/AN/AN/AN/A
Forian Inc. stock logo
FORA
Forian
1.7203 of 5 stars
3.52.00.00.01.51.70.0
Kamada Ltd. stock logo
KMDA
Kamada
4.1491 of 5 stars
3.43.00.00.03.11.73.8
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
American Well Corporation stock logo
AMWL
American Well
2.14
Hold$9.6741.22% Upside
Augmedix, Inc. stock logo
AUGX
Augmedix
2.00
Hold$2.35N/A
Forian Inc. stock logo
FORA
Forian
3.00
Buy$5.00132.56% Upside
Kamada Ltd. stock logo
KMDA
Kamada
2.75
Moderate Buy$14.67103.70% Upside

Current Analyst Ratings Breakdown

Latest AUGX, FORA, AMWL, and KMDA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/23/2025
American Well Corporation stock logo
AMWL
American Well
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$10.00 ➝ $8.00
5/15/2025
Kamada Ltd. stock logo
KMDA
Kamada
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$15.00 ➝ $15.00
5/8/2025
American Well Corporation stock logo
AMWL
American Well
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$12.00 ➝ $9.00
5/8/2025
Kamada Ltd. stock logo
KMDA
Kamada
Sidoti
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
5/2/2025
American Well Corporation stock logo
AMWL
American Well
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$10.00 ➝ $8.00
5/2/2025
American Well Corporation stock logo
AMWL
American Well
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
4/10/2025
American Well Corporation stock logo
AMWL
American Well
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$12.00 ➝ $7.50
(Data available from 6/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
American Well Corporation stock logo
AMWL
American Well
$254.36M0.42N/AN/A$20.31 per share0.34
Augmedix, Inc. stock logo
AUGX
Augmedix
$51.58M2.23N/AN/A$0.56 per share4.20
Forian Inc. stock logo
FORA
Forian
$22.33M3.00N/AN/AN/A
Kamada Ltd. stock logo
KMDA
Kamada
$160.95M2.57$0.49 per share14.65$4.51 per share1.60
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
American Well Corporation stock logo
AMWL
American Well
-$208.14M-$10.19N/AN/AN/A-59.13%-48.36%-35.36%7/30/2025 (Estimated)
Augmedix, Inc. stock logo
AUGX
Augmedix
-$19.17M-$0.43N/AN/A-46.23%-182.36%-43.21%N/A
Forian Inc. stock logo
FORA
Forian
N/A-$0.09N/AN/AN/AN/AN/A8/13/2025 (Estimated)
Kamada Ltd. stock logo
KMDA
Kamada
$14.46M$0.2924.8322.500.879.60%6.31%4.43%8/13/2025 (Estimated)

Latest AUGX, FORA, AMWL, and KMDA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/14/2025Q1 2025
Forian Inc. stock logo
FORA
Forian
$0.02-$0.04-$0.06-$0.04$5.37 million$7.06 million
5/14/2025Q1 2025
Kamada Ltd. stock logo
KMDA
Kamada
$0.07$0.07N/A$0.07$154.06 million$44.02 million
5/1/2025Q1 2025
American Well Corporation stock logo
AMWL
American Well
-$3.09-$1.73+$1.36-$1.19$60.15 million$66.83 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
American Well Corporation stock logo
AMWL
American Well
N/AN/AN/AN/AN/A
Augmedix, Inc. stock logo
AUGX
Augmedix
N/AN/AN/AN/AN/A
Forian Inc. stock logo
FORA
Forian
N/AN/AN/AN/AN/A
Kamada Ltd. stock logo
KMDA
Kamada
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
American Well Corporation stock logo
AMWL
American Well
N/A
2.92
2.89
Augmedix, Inc. stock logo
AUGX
Augmedix
1.48
1.66
1.66
Forian Inc. stock logo
FORA
Forian
N/AN/AN/A
Kamada Ltd. stock logo
KMDA
Kamada
N/A
3.30
1.93

Institutional Ownership

CompanyInstitutional Ownership
American Well Corporation stock logo
AMWL
American Well
56.05%
Augmedix, Inc. stock logo
AUGX
Augmedix
87.11%
Forian Inc. stock logo
FORA
Forian
19.25%
Kamada Ltd. stock logo
KMDA
Kamada
20.38%

Insider Ownership

CompanyInsider Ownership
American Well Corporation stock logo
AMWL
American Well
12.80%
Augmedix, Inc. stock logo
AUGX
Augmedix
10.97%
Forian Inc. stock logo
FORA
Forian
34.30%
Kamada Ltd. stock logo
KMDA
Kamada
36.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
American Well Corporation stock logo
AMWL
American Well
1,04015.61 million13.61 millionOptionable
Augmedix, Inc. stock logo
AUGX
Augmedix
1,43048.97 million43.60 millionOptionable
Forian Inc. stock logo
FORA
Forian
14031.20 millionN/AOptionable
Kamada Ltd. stock logo
KMDA
Kamada
36057.51 million36.75 millionOptionable

Recent News About These Companies

Kamada Stock Price History
Kamada Ltd. stock logo
Kamada Ltd. (NASDAQ:KMDA) Short Interest Update

New MarketBeat Followers Over Time

Media Sentiment Over Time

American Well stock logo

American Well NYSE:AMWL

$6.84 +0.04 (+0.51%)
Closing price 06/20/2025 03:58 PM Eastern
Extended Trading
$6.82 -0.02 (-0.37%)
As of 06/20/2025 04:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members. It provides Carepoint devices comprising carts, peripherals, tablets, and TVs, which serve as digital access points in clinical settings. In addition, the company offers Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, acute psychiatry, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

Augmedix stock logo

Augmedix NASDAQ:AUGX

Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.

Forian stock logo

Forian NASDAQ:FORA

$2.15 +0.03 (+1.42%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$2.15 0.00 (0.00%)
As of 06/20/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Forian Inc. provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions. The company's subscription and services-based solutions cover the life sciences, pharma services, and healthcare payer and provider industries. Forian Inc. was founded in 2020 and is headquartered in Newtown, Pennsylvania.

Kamada stock logo

Kamada NASDAQ:KMDA

$7.20 -0.02 (-0.28%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$7.05 -0.15 (-2.07%)
As of 06/20/2025 06:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Kamada Ltd. manufactures and sells plasma-derived protein therapeutics. Its commercial products include KAMRAB/KEDRAB for treating prophylaxis of rabies; CYTOGAM for Prophylaxis of Cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplants; VARIZIG for post exposure prophylaxis of varicella; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; GLASSIA for intravenous AATD; KAMRHO (D) IM for prophylaxis of hemolytic disease of newborns; KAMRHO (D) IV for immune thermobocytopunic purpura; and Echis coloratus and Vipera palaestinae Antiserum for the treatment of snake bite. The company also distributes imported drug products in Israel, including BRAMITOB to manage chronic pulmonary infection; FOSTER to treat asthma; TRIMBOW for chronic obstructive pulmonary disease; PROVOCHOLINE for the diagnosis of bronchial airway hyperactivity; AEROBIKA, an OPEP device; RUPAFIN and RUPAFIN ORAL SOLUTION for allergic rhinitis and Urticaria; SINTREDIUS for rheumatoid arthritis, systemic lupus erythematosus, and mild-moderate juvenile dermatomyositis; IVIG for immunodeficiency-related conditions; VARITECT for chicken pox and zoster herpes; ZUTECTRA and HEPATECT CP for hepatitis B; MEGALOTECT CP for CMV virus; RUCONEST for angioedema attack; HEPARIN SODIUM INJECTION for thrombo-embolic disorders and prophylaxis of deep vein thrombosis and thromboembolic events; ALBUMIN and ALBUMIN for blood plasma; Factor VIII for hemophilia type A; and Factor IX for hemophilia type B. In addition, it distributes COAGADEX for hereditary factor X deficiency; IXIARO for Japanese encephalitis; VIVOTIF for Salmonella Typhi; PROCYSBI for nephropathic cystinosis; LAMZEDE for alpha-mannosidosis; ELIGARD for prostate cancer; and BEVACIZUMAB KAMADA for various cancers. The company was incorporated in 1990 and is headquartered in Rehovot, Israel.